Prostate Cancer Transatlantic Consortium CaPTC

About CaPTC
Because the problem of prostate cancer disparity persists, it is crucial that we begin to use new paradigms and look at the problem from fresh perspectives to develop effective solutions. The possibility for exploring new paradigms comes from studying Blacks who are connected to the U.S. via the Transatlantic Slave Trade.
 
The Prostate Cancer Transatlantic Consortium (CaPTC) was formed in 2005 to address the globally disproportionate burden of prostate cancer among Black men. CaPTC is an open consortium comprising a team of prostate cancer scientists, clinicians, survivors, and advocates from North America, Europe, the Caribbean Islands, and West Africa.
CaPTC's research goals are to:
explore and quantify the magnitude of prostate cancer morbidity and mortality variance among Black men;
explore the genetic and environmental etiology of this variance, using valid and reliable instruments and biomarkers; and
develop